Changes in aromatase (CYP19) gene promoter usage in non-small cell lung cancer

Lung Cancer

Volumn 73, Issue 3, 2011, Pages 289-293

  Demura, Masashi ^a,b   Demura, Yoshiki ^c   Ameshima, Shingo ^d   Ishizaki, Takeshi ^d   Sasaki, Masato ^d   Miyamori, Isamu ^d   Yamagishi, Masakazu ^b   Takeda, Yoshiyu ^b   Bulun, Serdar E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^d UNIVERSITY OF FUKUI HOSPITAL   (Japan)

Author keywords

Aromatase; CYP19; Estrogen; Non small cell lung cancer; Promoter; Promoter usage

Indexed keywords

AROMATASE; ESTROGEN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GENE ACTIVATION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; UPREGULATION;

ADULT; AGED; ALTERNATIVE SPLICING; AROMATASE; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; TRANSCRIPTIONAL ACTIVATION;

EID: 79960889611     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.01.003     Document Type: Article

References (24)

1. Sebastian S., Bulun S.E. A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project. J Clin Endocrinol Metab 2001, 86:4600-4602.
2. Bulun S.E., Sebastian S., Takayama K., Suzuki T., Sasano H., Shozu M. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol 2003, 86:219-224.
3. Kamat A., Mendelson C.R. Identification of the regulatory regions of the human aromatase P450 (CYP19) gene involved in placenta-specific expression. J Steroid Biochem Mol Biol 2001, 79:173-180.
4. Mahendroo M.S., Mendelson C.R., Simpson E.R. Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J Biol Chem 1993, 268:19463-19470.
5. Patrone C., Cassel T.N., Pettersson K., Piao Y.S., Cheng G., Ciana P., et al. Regulation of postnatal lung development and homeostasis by estrogen receptor beta. Mol Cell Biol 2003, 23:8542-8552.
6. Stabile L.P., Davis A.L., Gubish C.T., Hopkins T.M., Luketich J.D., Christie N., et al. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res 2002, 62:2141-2150.
7. Pietras R.J., Marquez D.C., Chen H.W., Tsai E., Weinberg O., Fishbein M. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids 2005, 70:372-381.
8. Pezzi V., Mathis J.M., Rainey W.E., Carr B.R. Profiling transcript levels for steroidogenic enzymes in fetal tissues. J Steroid Biochem Mol Biol 2003, 87:181-189.
9. Brodie A., Long B., Lu Q. Aromatase expression in the human breast. Breast Cancer Res Treat 1998, 49(Suppl. 1):S85-S91. [discussion S109-19].
10. Oyama T., Kagawa N., Sugio K., Uramoto H., Hatano O., Harada N., et al. Expression of aromatase CYP19 and its relationship with parameters in NSCLC. Front Biosci 2009, 14:2285-2292.
11. Weinberg O.K., Marquez-Garban D.C., Fishbein M.C., Goodglick L., Garban H.J., Dubinett S.M., et al. Aromatase inhibitors in human lung cancer therapy. Cancer Res 2005, 65:11287-11291.
12. Demura M., Reierstad S., Innes J.E., Bulun S.E. Novel promoter I.8 and promoter usage in the CYP19 (Aromatase) gene. Reprod Sci 2008, 15:1044-1053.
13. Ishikawa H., Reierstad S., Demura M., Rademaker A.W., Kasai T., Inoue M., et al. High aromatase expression in uterine leiomyoma tissues of African-American women. J Clin Endocrinol Metab 2009, 94:1752-1756.
14. Taioli E., Wynder E.L. Re: endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994, 86:869-870.
15. Mollerup S., Jorgensen K., Berge G., Haugen A. Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer 2002, 37:153-159.
16. Kawai H., Ishii A., Washiya K., Konno T., Kon H., Yamaya C., et al. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res 2005, 11:5084-5089.
17. Stabile L.P., Lyker J.S., Gubish C.T., Zhang W., Grandis J.R., Siegfried J.M. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res 2005, 65:1459-1470.
18. Marquez-Garban D.C., Chen H.W., Goodglick L., Fishbein M.C., Pietras R.J. Targeting aromatase and estrogen signaling in human non-small cell lung cancer. Ann N Y Acad Sci 2009, 1155:194-205.
19. Meng L., Zhou J., Sasano H., Suzuki T., Zeitoun K.M., Bulun S.E. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction. Cancer Res 2001, 61:2250-2255.
20. Zhou J., Gurates B., Yang S., Sebastian S., Bulun S.E. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta. Cancer Res 2001, 61:2328-2334.
21. Bulun S.E., Lin Z., Imir G., Amin S., Demura M., Yilmaz B., et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 2005, 57:359-383.
22. Zhao Y., Agarwal V.R., Mendelson C.R., Simpson E.R. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 1996, 137:5739-5742.
23. Shozu M., Sumitani H., Segawa T., Yang H.J., Murakami K., Kasai T., et al. Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19). J Clin Endocrinol Metab 2002, 87:2540-2548.
24. Sebastian S., Takayama K., Shozu M., Bulun S.E. Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue. Mol Endocrinol 2002, 16:2243-2254.